Marathon Petroleum closes the week down 5.2% at $389.68, with the stock retreating from its recent highs even as the bull thesis from Goldman Sachs and Morgan Stanley remains formally intact — the week's defining tension is between a still-bullish analyst majority and options traders who have now loaded the most defensive positioning of the past year.
The options market is the loudest signal this week. The put/call ratio reached 1.15 on Tuesday, its highest reading of the past 52 weeks outside the 1.18 peak, and nearly two standard deviations above its 20-day mean of 0.95. That level of put demand doesn't appear in a vacuum: it has been building steadily since mid-August, when the ratio was running below 0.70. The pattern suggests investors who have ridden the stock's remarkable year-to-date rally — up around 88% — are now paying to protect those gains rather than add new upside exposure heading into the October 27 earnings print.
Short positioning, by contrast, tells a much quieter story. Short interest fell another 19% across the week to 2.35% of free float, the lowest level in months, with roughly 1.65 million shares covered in five sessions. Borrow availability is effectively unlimited at over 3,000% — meaning there are around 30 shares available to lend for every one currently borrowed. Cost to borrow sits at just 0.43%. There is no squeeze setup, no crowding, and no sign the remaining bears are paying any premium to hold their ground. The short-side exit and the options-market caution are pulling in opposite directions, and that divergence is the week's clearest positioning story.
On the Street, the consensus is still skewed bullish but the week added a meaningful crack. Jefferies downgraded to Hold on September 22 with a $413 target — the first outright rating cut in the recent wave of analyst activity. That move lands awkwardly alongside Goldman Sachs raising to $472 (Buy, September 21) and Morgan Stanley's $453 target (Overweight, September 14). The bulls remain in the majority: five of the fifteen covering analysts are at Buy or equivalent, nine at Hold, and just one at Underperform. But the Jefferies cut matters because it arrived the day after Goldman reaffirmed, making the divergence explicit and public. Valuation multiples have been compressing through the week — the PE multiple has dropped about 1.1 turns over seven days to 7.9x — even as EPS momentum factor scores remain exceptionally strong at the 93rd and 92nd percentiles on the 30- and 90-day windows. The stock's earnings history adds texture: MPC fell 3% the day after its most recent August report, but recovered over 9% in the following five sessions. With Q3 results due October 27, that pattern is worth keeping in view.
The refining peer group offered no shelter this week. VLO fell 5.0%, DINO dropped 5.0%, and PSX gave back 3.1% — a sector-wide retreat that takes some of the idiosyncratic sting out of MPC's decline but confirms the macro headwind is real. Insider activity has been net negative over the past 90 days, with a net $11.5 million in shares sold, though the most recent transactions of note — option exercises and matched sales by the Chief Legal Officer in August — were conducted under pre-arranged 10b5-1 plans and carry limited informational weight.
What to watch into October: whether the put/call ratio sustains above 1.10 as the earnings date approaches, and whether any of the holdout analysts anchored to lower targets move to close the gap with Goldman and Morgan Stanley's revised numbers.
See the live data behind this article on ORTEX.
Open MPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
